Table I.
holo-hDAAO |
apo-hDAAO |
hDAAO-pLG72 complex |
||||||||
---|---|---|---|---|---|---|---|---|---|---|
A1 (%) | k1 (min−1) | A2 (%) | k2 (min−1) | A1 (%) | k1 (min−1) | A1 (%) | k1 (min−1) | A2 (%) | k2 (min−1) | |
No ligands | 68 ± 3 | 0.30 ± 0.04 | 32 ± 3 | 0.7 ± 0.2 ×10−2 | 100 | 0.27 ± 0.04 | 58 ± 8 | 0.55 ± 0.18 | 42 ± 8 | 6.0 ± 1.1 × 10−2 |
+ 0.1 mM FAD | 26 ± 4 | 0.32 ± 0.12 | 74 ± 4 | (≈ stable) | 66 ± 5 | 0.34 ± 0.08 | 23 ± 3 | 0.55 ± 0.10 | 77 ± 3 | 3.3 ± 0.4 × 10−2 |
+ 1 mM benzoate | 56 ± 3 | 0.48 ± 0.12 | 44 ± 3 | (≈ stable) | 100 | 0.27 ± 0.04 | 56 ± 5 | 0.60 ± 0.09 | 44 ± 6 | (≈ stable) |
+ 30 mM CF3-d-Ala | 56 ± 4 | 0.32 ± 0.09 | 44 ± 1 | (≈ stable) | 100 | 0.27 ± 0.04 | 49 ± 6 | 0.7 ± 0.23 | 51 ± 4 | (≈ stable) |
+ 0.1 mM CPZ | 68 ± 2 | 0.30 ± 0.02 | 32 ± 2 | 6.0 ± 1.8 ×10−2 | 100 | 0.27 ± 0.04 | 100 | 0.14 ± 0.01 | — | — |
+ 10 μM pLG72 | 42 ± 9 | 0.55 ± 0.18 | 58 ± 8 | 6.8 ± 1.1 ×10−2 | 100 | 0.30 ± 0.04 | ||||
+ 20 μM pLG72 | 58 ± 6 | 3.6 ± 0.7 | 42 ± 5 | 0.16 ± 0.03 | 100 | 0.27 ± 0.02 |